本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tyra Biosciences, Inc.

18.56
-1.0400-5.31%
盘后:18.560.00000.00%19:30 EDT
成交量:46.95万
成交额:880.05万
市值:12.76亿
市盈率:-7.72
高:19.60
开:19.39
低:18.54
收:19.60
52周最高:40.65
52周最低:13.35
股本:6,875.59万
流通股本:4,000.56万
量比:0.78
换手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
净资产收益率:-45.31%
总资产收益率:-28.46%
市净率:3.61
市盈率(LYR):-9.22

数据加载中...

2022/03/03

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/03

重要事件披露

8-K - Current report
2022/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

重要事件披露

8-K - Current report
2021/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/24

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/17

重要事件披露

8-K - Current report
2021/09/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/20

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/08/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/20

SEC问询函

CORRESP [Cover] - Correspondence